Quit4TB Trial

This project is based at ARK in Bangladesh & TI in Pakistan.

Overview

Project title: Quit 4 TB Trial in Bangladesh and Pakistan

Programme: Preventable Risk Factors

Based at: ARK Foundation in Bangladesh & The Initiative in Pakistan

Start date: September/October 2022

End date:

Principal Investigators (PIs): Kamran Siddiqi, Amina Khan & Rumana Huque

Project team: Samina Huque, Asiful Haidar Chowdhury, Fahmidur Rahman, Shakhawat Hossain Rana, Mahmoud Danaee, Ai Keow Lim, John Norrie, Steve Parrott, Linda Bauld, Genevie Fernandes, Melanie Böckmann

Quit4TB project logo
Quit4TB project logo

Background

Tuberculosis (TB) and tobacco smoking are co-epidemics that disproportionately affect many low and middle-income countries (LMICs). People who smoke are more likely to become infected with TB, be more infectious and develop worse health outcomes compared to their non-smoker counterparts.

RESPIRE researchers, in collaboration with the World Health Organization, had previously developed a mobile Health programme known as mTB-Tobacco. The programme is designed to support people recovering from TB who also wish to stop smoking by sending carefully crafted and timed SMS messages to their mobile devices as they undergo treatment for TB.

 

Aim and Impact

This project aims to assess the effectiveness and cost effectiveness of mTB-Tobacco in Bangladesh and Pakistan – two countries with a high disease burden of TB and tobacco.

 

Milestones

 

This article was published on